Literature DB >> 13183798

Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. 5. Reanalysis of results based on laboratory-confirmed cases.

W M HAMMON, L L CORIELL, E H LUDWIG, R M McALLISTER, A E GREENE, G E SATHER, P F WEHRLE.   

Abstract

Entities:  

Keywords:  GAMMA GLOBULIN/therapeutic use; POLIOMYELITIS/prevention and control

Mesh：

Substances：

Year:  1954        PMID： 13183798     DOI： 10.1001/jama.1954.02950010023009

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN： 0002-9955


× No keyword cloud information.
  13 in total

1.  Approach to control of poliomyelitis by immunological methods.

Authors:  T FRANCIS
Journal:  Bull N Y Acad Med       Date:  1955-04

2.  [Prevention of poliomyelitis; present and future].

Authors:  P LEPINE
Journal:  Bull World Health Organ       Date:  1955       Impact factor: 9.408

Review 3.  Neonatal enterovirus infection.

Authors:  J A Jenista; M A Menegus
Journal:  Indian J Pediatr       Date:  1988 Mar-Apr       Impact factor: 1.967

4.  Passive immunization against poliomyelitis: the Hammon gamma globulin field trials, 1951-1953.

Authors:  Charles R Rinaldo
Journal:  Am J Public Health       Date:  2005-05       Impact factor: 9.308

5.  Poliomyelitis in 1953.

Authors:  M J FREYCHE; A M PAYNE; C LEDERREY
Journal:  Bull World Health Organ       Date:  1955       Impact factor: 9.408

Review 6.  Immunogenicity and effectiveness of routine immunization with 1 or 2 doses of inactivated poliovirus vaccine: systematic review and meta-analysis.

Authors:  Nicholas C Grassly
Journal:  J Infect Dis       Date:  2014-03-14       Impact factor: 5.226

7.  Comparison of IPV to tOPV week 39 boost of primary OPV vaccination in Indian infants: an open labelled randomized controlled trial.

Authors:  Suman Kanungo; Deok Ryun Kim; Bisakha Haldar; Cynthia Snider; Uma Nalavade; Soon Ae Kim; Ju Yeon Park; Anuradha Sinha; Aiyel Haque Mallick; Byomkesh Manna; Dipika Sur; Ranjan Kumar Nandy; Jagadish M Deshpande; Cecil Czerkinsky; Thomas F Wierzba; William A Petri; Mohammad Ali; Ayan Dey
Journal:  Heliyon       Date:  2017-01-09

8.  The clinical trials on gamma globulin for polio: victims of marketing success

Authors:  Stephen E Mawdsley
Journal:  CMAJ       Date:  2017-07-24       Impact factor: 8.262

Review 9.  Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame.

Authors:  Edward Pk Parker; Natalie A Molodecky; Margarita Pons-Salort; Kathleen M O'Reilly; Nicholas C Grassly
Journal:  Expert Rev Vaccines       Date:  2015-07-09       Impact factor: 5.217

10.  Human Circulating Antibody-Producing B Cell as a Predictive Measure of Mucosal Immunity to Poliovirus.

Authors:  Ayan Dey; Natalie A Molodecky; Harish Verma; Prashant Sharma; Jae Seung Yang; Giulietta Saletti; Mohammad Ahmad; Sunil K Bahl; Thomas F Wierzba; Ranjan K Nandy; Jagadish M Deshpande; Roland W Sutter; Cecil Czerkinsky
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.